MemoDefend Reviews – Negative Side Effects or Real Benefits?
April 09, 2021 19:47 ET
|
Marketing By Kevin
Chicago, IL, April 09, 2021 (GLOBE NEWSWIRE) -- Memo Defend is a dietary supplement that claims to help older adults recover from total memory loss using a variety of high powered natural...
TINA.org Files FTC Complaint Against “Brain Training” Company Neurocore
November 12, 2019 13:31 ET
|
truthinadvertising.org
MADISON, CONN., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Ad watchdog truthinadvertising.org (TINA.org) has filed a complaint with the Federal Trade Commission (FTC) against Neurocore, a “brain training"...
Cognition Therapeutics Initiates NIA-Funded SPARC Study of Elayta™ to Assess Changes in Synaptic Density and Cognitive Performance in Alzheimer's Disease
June 18, 2018 08:03 ET
|
Cognition Therapeutics, Inc.
Pittsburgh, June 18, 2018 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on synaptic health and restoration in neurocognitive disorders, today...
Kmart Pharmacy Joins Alzheimer’s Foundation of America to Raise Awareness and Offer Free Memory Screenings Nationwide this May
April 26, 2018 09:26 ET
|
Alzheimer's Foundation of America
NEW YORK, April 26, 2018 (GLOBE NEWSWIRE) -- The Alzheimer’s Foundation of America (AFA) and Kmart Pharmacy are continuing their strong collaboration in 2018, as Kmart will conduct free memory...
Alzheimer’s Virtual Reality Sensory Experience Featured at Upcoming ASA Workshop
March 23, 2018 09:31 ET
|
Alzheimer's Foundation of America
SAN FRANCISCO, March 23, 2018 (GLOBE NEWSWIRE) -- The Alzheimer’s Foundation of America (AFA)—in collaboration with Greener Media—is hosting a workshop titled, "What Would You Do: A Sensory...
Cognition Therapeutics Co-Founder and CSO Susan Catalano to Present at the Annual ASENT Meeting
March 06, 2018 14:04 ET
|
Cognition Therapeutics, Inc.
Pittsburgh, March 06, 2018 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the development of innovative therapeutics for the treatment of...
Cognition Therapeutics Co-Founder and CSO Susan Catalano to Present at Sachs Neuroscience Innovation Forum
January 04, 2018 08:05 ET
|
Cognition Therapeutics, Inc.
Pittsburgh, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the development of innovative therapeutics for the treatment of...
Cognition Therapeutics CEO Kenneth I. Moch to Present at the Stifel 2017 Healthcare Conference
November 08, 2017 08:12 ET
|
Cognition Therapeutics, Inc.
Pittsburgh, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the development of innovative therapeutics for the treatment of...
Cognition Therapeutics CEO Kenneth I. Moch to Present at Canaccord Genuity Annual Growth Conference
July 31, 2017 08:30 ET
|
Cognition Therapeutics, Inc.
Pittsburgh, July 31, 2017 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the development of innovative therapeutics for the treatment of...
Cognition Therapeutics Reports Drug-Drug Interaction Results for CT1812, a Disease-Modifying Alzheimer’s Disease Candidate
July 19, 2017 04:35 ET
|
Cognition Therapeutics, Inc.
PITTSBURGH, July 19, 2017 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the development of innovative small molecule therapeutics for the...